It Is the Same Old Story at Boston Scientific (BSX)

Go back to It Is the Same Old Story at Boston Scientific (BSX)

Boston Scientific Corp. (BSX) Tops Q3 EPS by 5c; Issues Mixed Guidance

October 18, 2012 7:03 AM EDT

Boston Scientific Corp. (NYSE: BSX) reported Q3 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $1.74 billion versus the consensus estimate of $1.76 billion.

Boston Scientific Corp. sees FY2012 EPS of $0.63-0.66, which may not compare consensus of $0.42.... More